Peregrine has an extensive pipeline of platform technologies which are in various stages of pre-clinical and clinical development. The company’s current philosophy is to conduct basic research and early clinical development on technologies prior to licensing them to larger pharmaceutical companies for commercialization, although Peregrine may choose to develop and market its products for targeted or specialized uses on its own. Peregrine currently has numerous products in pre-clinical development and two products in clinical trials. It is pursuing therapeutic and diagnostic compounds in the following technology fields: